BIOA
BioAge Labs, Inc
NASDAQ: BIOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.47
+9.62% today
Updated 2026-10-27
Market cap
$229.03M
P/E ratio
—
P/S ratio
22.12x
EPS (TTM)
$-2.46
Dividend yield
—
52W range
$5 – $26
Volume
0.7M
BioAge Labs, Inc (BIOA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.47
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2017 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 1.69% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.